The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures.
【저자키워드】 COVID-19, Chemotherapy, Leukaemia, 【초록키워드】 SARS-CoV-2, coronavirus, pandemic, COVID-19 pandemic, hospital, Diagnosis, risk, outcome, Prophylactic, Case report, Spread, Measures, Patient, Cancer patients, Immunocompromised, complications, Care, cancer treatment, mild symptoms, cancer patient, acute respiratory syndrome, hematological, while, infecting, benefit, develop, globe, appear, with COVID-19, 【제목키워드】 Case report, COVID-19 infection, Patient, leukemia,